FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000654777> ?p ?o ?g. }

• W2000654777 endingPage "4368" @default.
• W2000654777 startingPage "4361" @default.
• W2000654777 abstract "Genital herpes caused by herpes simplex virus type 2 (HSV-2) remains the leading cause of genital ulcers worldwide. Given the disappointing results of the recent genital herpes vaccine trials in humans, development of novel vaccine strategies capable of eliciting protective mucosal and systemic immune responses to HSV-2 is urgently required. Here we tested the ability of the adjuvant IC31® in combination with HSV-2 glycoprotein D (gD) used through intranasal (i.n.), intradermal (i.d.), or subcutaneous (s.c.) immunization routes for induction of protective immunity against genital herpes infection in C57BL/6 mice. Immunization with gD plus IC31® through all three routes of immunization developed elevated gD-specific serum antibody responses with HSV-2 neutralizing activity. Whereas the skin routes promoted the induction of a mixed IgG2c/IgG1 isotype profile, the i.n. route only elicited IgG1 antibodies. All immunization routes were able to induce gD-specific IgG antibody responses in the vaginas of mice immunized with IC31®-adjuvanted gD. Although specific lymphoproliferative responses were observed in splenocytes from mice of most groups vaccinated with IC31®-adjuvanted gD, only i.d. immunization resulted in a significant splenic IFN-γ response. Further, immunization with gD plus IC31® conferred 80–100% protection against an otherwise lethal vaginal HSV-2 challenge with amelioration of viral replication and disease severity in the vagina. These results warrant further exploration of IC31® for induction of protective immunity against genital herpes and other sexually transmitted infections." @default.
• W2000654777 created "2016-06-24" @default.
• W2000654777 creator A5030966540 @default.
• W2000654777 creator A5045405162 @default.
• W2000654777 creator A5062051619 @default.
• W2000654777 creator A5066205556 @default.
• W2000654777 creator A5089715150 @default.
• W2000654777 date "2012-06-01" @default.
• W2000654777 modified "2023-09-26" @default.
• W2000654777 title "Nasal and skin delivery of IC31®-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes" @default.
• W2000654777 cites W1585389173 @default.
• W2000654777 cites W1603446342 @default.
• W2000654777 cites W1968878008 @default.
• W2000654777 cites W1970636290 @default.
• W2000654777 cites W1976933874 @default.
• W2000654777 cites W1977575192 @default.
• W2000654777 cites W1978672774 @default.
• W2000654777 cites W1981732883 @default.
• W2000654777 cites W1982895831 @default.
• W2000654777 cites W1983763479 @default.
• W2000654777 cites W2002392006 @default.
• W2000654777 cites W2003182795 @default.
• W2000654777 cites W2003344929 @default.
• W2000654777 cites W2004789593 @default.
• W2000654777 cites W2004908730 @default.
• W2000654777 cites W2013103459 @default.
• W2000654777 cites W2019840235 @default.
• W2000654777 cites W2024909307 @default.
• W2000654777 cites W2028341220 @default.
• W2000654777 cites W2035214942 @default.
• W2000654777 cites W2037938966 @default.
• W2000654777 cites W2044185990 @default.
• W2000654777 cites W2045693101 @default.
• W2000654777 cites W2045971655 @default.
• W2000654777 cites W2046941690 @default.
• W2000654777 cites W2051780114 @default.
• W2000654777 cites W2067030124 @default.
• W2000654777 cites W2068414987 @default.
• W2000654777 cites W2075515775 @default.
• W2000654777 cites W2089226849 @default.
• W2000654777 cites W2095068782 @default.
• W2000654777 cites W2095925146 @default.
• W2000654777 cites W2098772355 @default.
• W2000654777 cites W2103086818 @default.
• W2000654777 cites W2112076672 @default.
• W2000654777 cites W2147328386 @default.
• W2000654777 cites W2156244991 @default.
• W2000654777 cites W2156555210 @default.
• W2000654777 cites W2160680185 @default.
• W2000654777 cites W2166681399 @default.
• W2000654777 cites W2169447203 @default.
• W2000654777 cites W2171989849 @default.
• W2000654777 cites W2235274525 @default.
• W2000654777 cites W2236109795 @default.
• W2000654777 cites W4243814655 @default.
• W2000654777 doi "https://doi.org/10.1016/j.vaccine.2012.02.019" @default.
• W2000654777 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22682292" @default.
• W2000654777 hasPublicationYear "2012" @default.
• W2000654777 type Work @default.
• W2000654777 sameAs 2000654777 @default.
• W2000654777 citedByCount "20" @default.
• W2000654777 countsByYear W20006547772013 @default.
• W2000654777 countsByYear W20006547772014 @default.
• W2000654777 countsByYear W20006547772015 @default.
• W2000654777 countsByYear W20006547772016 @default.
• W2000654777 countsByYear W20006547772017 @default.
• W2000654777 countsByYear W20006547772018 @default.
• W2000654777 countsByYear W20006547772022 @default.
• W2000654777 countsByYear W20006547772023 @default.
• W2000654777 crossrefType "journal-article" @default.
• W2000654777 hasAuthorship W2000654777A5030966540 @default.
• W2000654777 hasAuthorship W2000654777A5045405162 @default.
• W2000654777 hasAuthorship W2000654777A5062051619 @default.
• W2000654777 hasAuthorship W2000654777A5066205556 @default.
• W2000654777 hasAuthorship W2000654777A5089715150 @default.
• W2000654777 hasConcept C12914427 @default.
• W2000654777 hasConcept C137061746 @default.
• W2000654777 hasConcept C159047783 @default.
• W2000654777 hasConcept C159654299 @default.
• W2000654777 hasConcept C202751555 @default.
• W2000654777 hasConcept C203014093 @default.
• W2000654777 hasConcept C22070199 @default.
• W2000654777 hasConcept C2522874641 @default.
• W2000654777 hasConcept C2776969849 @default.
• W2000654777 hasConcept C2777863537 @default.
• W2000654777 hasConcept C2779341262 @default.
• W2000654777 hasConcept C2780801004 @default.
• W2000654777 hasConcept C2781196997 @default.
• W2000654777 hasConcept C55493867 @default.
• W2000654777 hasConcept C71924100 @default.
• W2000654777 hasConcept C86803240 @default.
• W2000654777 hasConcept C8891405 @default.
• W2000654777 hasConceptScore W2000654777C12914427 @default.
• W2000654777 hasConceptScore W2000654777C137061746 @default.
• W2000654777 hasConceptScore W2000654777C159047783 @default.
• W2000654777 hasConceptScore W2000654777C159654299 @default.
• W2000654777 hasConceptScore W2000654777C202751555 @default.
• W2000654777 hasConceptScore W2000654777C203014093 @default.

• next